UnitedHealth Stock Hits ’Rock Bottom’ as Investor Sees Opportunity Amid Decline

UnitedHealth's stock plummeted nearly 50% between mid-April and mid-May following a disappointing Q1 2025 earnings report—its first miss since 2008. The healthcare giant faced compounding setbacks, including a CEO resignation, withdrawn guidance, and heightened regulatory scrutiny from the Center for Medicare and Medicaid Services.

Pseudonymous investor WHITE Star Research argues the selloff has created a rare buying opportunity. 'This could present a tremendous opportunity to acquire shares of a systemically important company in solid financial shape,' the investor noted, suggesting UNH has reached a valuation floor with 'only one direction to flow.'

Market observers now watch whether the stock stabilizes or begins a gradual recovery. The episode underscores how even blue-chip equities face turbulence when earnings momentum falters amid operational challenges.